Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01276080 · ClinicalTrials.gov registry record · Phase 1
Bioequivalence Study of Donepezil Hydrochloride 10 mg Tablets Under Fed Conditions
A Phase 1 study, sponsored by Ranbaxy Laboratories Limited.
- Completed
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
NCT01276080: Completed Phase 1 study, sponsored by Ranbaxy Laboratories Limited.
NCT01276080 is a Phase 1 study that has completed, run by Ranbaxy Laboratories Limited. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01276080, a Phase 1 study, has completed, sponsored by Ranbaxy Laboratories Limited.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
Study Summary
This open label, balanced, randomized, two-treatment, two-period, two-sequence, single dose crossover study was conducted to compare the relative bioavailability of equal doses of the test and reference products under non-fasted conditions.
Interventions
- DRUG Donepezil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2009-10 |
| Est. Completion | 2009-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01276080
The ClinicalTrials.gov registry entry for NCT01276080 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ranbaxy Laboratories Limited, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Donepezil is the first listed.
NCT01276080 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01276080 about?
NCT01276080 is a clinical study titled "Bioequivalence Study of Donepezil Hydrochloride 10 mg Tablets Under Fed Conditions". This open label, balanced, randomized, two-treatment, two-period, two-sequence, single dose crossover study was conducted to compare the relative bioavailability of equal doses of the test and reference products under non-fasted conditions.
What is the current status of trial NCT01276080?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2009-10. Estimated completion is 2009-12.
What interventions are being tested in trial NCT01276080?
The interventions under investigation include: Donepezil (DRUG).
Who is sponsoring clinical trial NCT01276080?
This trial is sponsored by Ranbaxy Laboratories Limited, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.